Immunoglobulin Allotypes in Hepatitis C Virus Infection

丙型肝炎病毒感染中的免疫球蛋白同种异型

基本信息

  • 批准号:
    7188051
  • 负责人:
  • 金额:
    $ 19.06万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-03-01 至 2009-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Hepatitis C virus (HCV) is a major health problem, affecting over 170 million people worldwide. Of persons acutely infected with HCV, about 15% spontaneously clear the virus. Because of limitations in experimental models and the infrequent recognition of natural acute infection, the mechanisms of viral clearance are poorly understood. There are clinical and epidemiologic clues that suggest host factors are critical. Among the factors influencing the outcome of HCV infection, the host genetic factors are thought to play a predominant role. Immunoglobulin (Ig) GM and KM allotypes-hereditary antigenic determinants of IgG heavy chains and k-type light chains, respectively-are associated with viral immunological properties, and thus are ideal candidate genetic systems for investigations to identify risk-conferring factors in HCV pathogenesis. We hypothesized that GM and KM allotypes may contribute to the outcome of HCV infection through their possible influence on allotype-restricted antibody responses to the viral antigens. Additionally, they may influence antibody dependent T cell cytotoxicity to HCV by their differential interaction with Fcgamma receptors (FcgammaR). GM and KM allotypes could also modulate the strategies-Ig molecular mimicry and FcgammaR-like activity-employed by this virus to evade host immune surveillance. To test our hypothesis, a case control study has been designed with the following specific aims: (1) to further establish the magnitude of association between the outcome of HCV infection and Ig GM and KM allotypes in African Americans; (2) to determine if GM and KM allotypes are associated with the outcome of HCV infection in Caucasians; (3) to measure the specificity and titer of the humoral immune responses to HCV antigens (core, E1,E2,NS3,NS4,NS5) and determine if the production of these antibodies is influenced by GM and KM allotypes; (4) to determine if HCV-encoded FcgammaR binds differentially with IgG molecules carrying different GM allotypes. GM and KM allotyping will be done by hemagglutination-inhibition, direct DNA sequencing, and PCR-RFLP methods. IgG antibodies to HCV antigens will be measured by an ELISA. Binding and comparative affinities of IgG molecules of different GM allotypes to HCV-FcgammaR will be monitored by surface plasmon resonance detection. Results of this investigation will advance our understanding of the role of host genetic factors in clearance and persistence of hepatitis C virus infection.
描述(由申请人提供):丙型肝炎病毒(HCV)是一种主要的健康问题,影响全球超过1.7亿人。在急性感染HCV的人中,约15%的人自发清除病毒。由于实验模型的局限性和对自然急性感染的认识不多,对病毒清除的机制知之甚少。有临床和流行病学线索表明宿主因素至关重要。在影响HCV感染结局的因素中,宿主遗传因素被认为起着主导作用。免疫球蛋白(IG)GM和KM同种异型-IgG重链和K-型轻链的遗传抗原决定簇,分别与病毒的免疫特性,因此是理想的候选遗传系统的调查,以确定在HCV发病的危险因素。我们假设GM和KM同种异型可能通过其对同种异型限制性抗体对病毒抗原的反应的可能影响而导致HCV感染的结果。此外,它们可以通过与Fc γ受体(Fc γ R)的差异相互作用来影响抗体依赖性T细胞对HCV的细胞毒性。GM和KM同种异型也可以调节该病毒逃避宿主免疫监视的策略-Ig分子模拟和Fc γ R样活性。为了验证我们的假设,我们设计了一项病例对照研究,其具体目的是:(1)进一步确定非裔美国人中HCV感染的结果与IG GM和KM同种异型之间的关联程度;(2)确定GM和KM同种异型是否与白人中HCV感染的结果相关;(3)检测抗HCV抗原的体液免疫反应的特异性和滴度(核心,E1,E2,NS 3,NS 4,NS 5),并确定这些抗体的产生是否受GM和KM同种异型的影响;(4)确定HCV编码的Fc γ R是否与携带不同GM同种异型的IgG分子差异结合。将通过血凝抑制、直接DNA测序和PCR-RFLP方法进行GM和KM同种异型分型。将通过ELISA测量HCV抗原的IgG抗体。将通过表面等离子体共振检测监测不同GM同种异型的IgG分子与HCV-Fc γ R的结合和比较亲和力。这项研究的结果将促进我们对宿主遗传因素在丙型肝炎病毒感染的清除和持续中的作用的理解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JANARDAN P PANDEY其他文献

JANARDAN P PANDEY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JANARDAN P PANDEY', 18)}}的其他基金

Immunoglobulin Genes and Immunity to HSV1 in Alzheimer's Disease
阿尔茨海默病中的免疫球蛋白基因和 HSV1 免疫
  • 批准号:
    10576613
  • 财政年份:
    2023
  • 资助金额:
    $ 19.06万
  • 项目类别:
IGHG Genes (GM Allotypes) and Anti-CMV (UL70) Antibody Responses as Prognostic Markers for Chronic Graft-Versus-Host-Disease
IGHG 基因(GM 同种型)和抗 CMV (UL70) 抗体反应作为慢性移植物抗宿主病的预后标志物
  • 批准号:
    10624498
  • 财政年份:
    2023
  • 资助金额:
    $ 19.06万
  • 项目类别:
FCGRIIIA and IGHG (GM) Genotypes and Immunity to HSV1 in Herpes Stromal Keratitis
疱疹性基质性角膜炎中的 FCGRIIIA 和 IGHG (GM) 基因型以及对 HSV1 的免疫
  • 批准号:
    10675575
  • 财政年份:
    2022
  • 资助金额:
    $ 19.06万
  • 项目类别:
FCGRIIIA and IGHG (GM) Genotypes and Immunity to HSV1 in Herpes Stromal Keratitis
疱疹性基质性角膜炎中的 FCGRIIIA 和 IGHG (GM) 基因型以及对 HSV1 的免疫
  • 批准号:
    10507311
  • 财政年份:
    2022
  • 资助金额:
    $ 19.06万
  • 项目类别:
Immunoglobulin GM (γ marker) Allotypes and Immunity to HSV1 in Alzheimer’s Disease
阿尔茨海默病中免疫球蛋白 GM(γ 标记)同种异型和对 HSV1 的免疫
  • 批准号:
    10464940
  • 财政年份:
    2021
  • 资助金额:
    $ 19.06万
  • 项目类别:
Genetic Markers of IgG and Cytomegalovirus Immunoevasion in Alzheimer Disease
阿尔茨海默病中 IgG 和巨细胞病毒免疫逃避的遗传标记
  • 批准号:
    9386264
  • 财政年份:
    2017
  • 资助金额:
    $ 19.06万
  • 项目类别:
Genetic Modifiers of Immune Evasion by Cytomegalovirus in Glioblastoma
胶质母细胞瘤中巨细胞病毒免疫逃避的基因修饰
  • 批准号:
    8465930
  • 财政年份:
    2012
  • 资助金额:
    $ 19.06万
  • 项目类别:
Genetic Modifiers of Immune Evasion by Cytomegalovirus in Glioblastoma
胶质母细胞瘤中巨细胞病毒免疫逃避的基因修饰
  • 批准号:
    8374071
  • 财政年份:
    2012
  • 资助金额:
    $ 19.06万
  • 项目类别:
Immunoglobulin Allotypes in Hepatitis C Virus Infection
丙型肝炎病毒感染中的免疫球蛋白同种异型
  • 批准号:
    7029163
  • 财政年份:
    2006
  • 资助金额:
    $ 19.06万
  • 项目类别:
Immunoglobulin Allotypes in Hepatitis C Virus Infection
丙型肝炎病毒感染中的免疫球蛋白同种异型
  • 批准号:
    7367031
  • 财政年份:
    2006
  • 资助金额:
    $ 19.06万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.06万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 19.06万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.06万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.06万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.06万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.06万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.06万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 19.06万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 19.06万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 19.06万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了